XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Financial Statement Details - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Accrued compensation $ 7,384 $ 5,553
Accrued clinical trial expenses 4,233 4,321
Liability to collaboration partners 1,310 2,678
Accrued contract termination costs 3,043 3,020
Other accrued expenses 8,311 6,590
Total accrued expenses $ 24,281 $ 22,162